Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23196674)

1.

Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer.

Havelund BM, Holdgaard PC, Rafaelsen SR, Mortensen LS, Theil J, Bender D, Pløen J, Spindler KL, Jakobsen A.

Nucl Med Commun. 2013 Feb;34(2):155-61. doi: 10.1097/MNM.0b013e32835bd5bc.

PMID:
23196674
2.

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study.

Souvatzoglou M, Grosu AL, Röper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla HJ, Wester HJ, Piert M.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1566-75. Epub 2007 Apr 20.

PMID:
17447061
3.

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.

Bollineni VR, Kerner GS, Pruim J, Steenbakkers RJ, Wiegman EM, Koole MJ, de Groot EH, Willemsen AT, Luurtsema G, Widder J, Groen HJ, Langendijk JA.

J Nucl Med. 2013 Aug;54(8):1175-80. doi: 10.2967/jnumed.112.115014. Epub 2013 Jun 10.

4.

Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).

Postema EJ, McEwan AJ, Riauka TA, Kumar P, Richmond DA, Abrams DN, Wiebe LI.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1565-73. doi: 10.1007/s00259-009-1154-5. Epub 2009 May 9.

PMID:
19430784
5.

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.

Grosu AL, Souvatzoglou M, Röper B, Dobritz M, Wiedenmann N, Jacob V, Wester HJ, Reischl G, Machulla HJ, Schwaiger M, Molls M, Piert M.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):541-51.

PMID:
17869667
6.

A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.

Servagi-Vernat S, Differding S, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1544-52. doi: 10.1007/s00259-014-2730-x. Epub 2014 Feb 26.

PMID:
24570097
7.

Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Maier FC, Kneilling M, Reischl G, Cay F, Bukala D, Schmid A, Judenhofer MS, Röcken M, Machulla HJ, Pichler BJ.

Radiat Oncol. 2011 Nov 25;6:165. doi: 10.1186/1748-717X-6-165.

8.

Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.

Trinkaus ME, Blum R, Rischin D, Callahan J, Bressel M, Segard T, Roselt P, Eu P, Binns D, MacManus MP, Ball D, Hicks RJ.

J Med Imaging Radiat Oncol. 2013 Aug;57(4):475-81. doi: 10.1111/1754-9485.12086. Epub 2013 Jun 14.

PMID:
23870348
9.

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.

Mortensen LS, Johansen J, Kallehauge J, Primdahl H, Busk M, Lassen P, Alsner J, Sørensen BS, Toustrup K, Jakobsen S, Petersen J, Petersen H, Theil J, Nordsmark M, Overgaard J.

Radiother Oncol. 2012 Oct;105(1):14-20. doi: 10.1016/j.radonc.2012.09.015. Epub 2012 Oct 16.

10.

¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.

Chen L, Zhang Z, Kolb HC, Walsh JC, Zhang J, Guan Y.

Nucl Med Commun. 2012 Oct;33(10):1096-102. doi: 10.1097/MNM.0b013e3283571016.

PMID:
22836736
11.

¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.

Calvo FA, Sole CV, de la Mata D, Cabezón L, Gómez-Espí M, Alvarez E, Madariaga P, Carreras JL.

Eur J Nucl Med Mol Imaging. 2013 May;40(5):657-67. doi: 10.1007/s00259-013-2341-y. Epub 2013 Feb 23.

PMID:
23436067
12.

18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.

Calvo FA, Domper M, Matute R, Martínez-Lázaro R, Arranz JA, Desco M, Alvarez E, Carreras JL.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):528-35.

PMID:
14751524
13.

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

Reischl G, Dorow DS, Cullinane C, Katsifis A, Roselt P, Binns D, Hicks RJ.

J Pharm Pharm Sci. 2007;10(2):203-11.

14.

Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.

Brændengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e439-45. doi: 10.1016/j.ijrobp.2011.03.031. Epub 2011 Jun 14.

PMID:
21641122
15.

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

Dietz DW, Dehdashti F, Grigsby PW, Malyapa RS, Myerson RJ, Picus J, Ritter J, Lewis JS, Welch MJ, Siegel BA.

Dis Colon Rectum. 2008 Nov;51(11):1641-8. doi: 10.1007/s10350-008-9420-3. Epub 2008 Aug 6.

PMID:
18682881
16.

The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.

Murcia Duréndez MJ, Frutos Esteban L, Luján J, Frutos MD, Valero G, Navarro Fernández JL, Mohamed Salem L, Ruiz Merino G, Claver Valderas MA.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):91-7. doi: 10.1007/s00259-012-2257-y. Epub 2012 Oct 19.

PMID:
23081822
17.

The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.

Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ.

Am J Clin Oncol. 2012 Aug;35(4):340-4. doi: 10.1097/COC.0b013e3182118e7d.

PMID:
21422901
18.

Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study.

Yue J, Yang Y, Cabrera AR, Sun X, Zhao S, Xie P, Zheng J, Ma L, Fu Z, Yu J.

Dis Esophagus. 2012 Jan;25(1):54-61. doi: 10.1111/j.1442-2050.2011.01209.x. Epub 2011 May 19.

PMID:
21595781
19.

New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.

Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH.

Clin Nucl Med. 2013 Jan;38(1):7-12. doi: 10.1097/RLU.0b013e3182639a58.

PMID:
23242038
20.

The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer.

Palma P, Conde-Muíño R, Rodríguez-Fernández A, Segura-Jiménez I, Sánchez-Sánchez R, Martín-Cano J, Gómez-Río M, Ferrón JA, Llamas-Elvira JM.

Radiat Oncol. 2010 Dec 15;5:119. doi: 10.1186/1748-717X-5-119.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk